Role of cytokines in preterm labor and birth

Minerva Ginecologica

Volumn 57, Issue 4, 2005, Pages 349-366

  Park, J S ^a   Park, C W ^a   Lockwood, C J ^b   Norwitz, E R ^b  

^a Seoul National University College of Medicine   (South Korea)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Intrauterine infection; Intrauterine inflammation; Preterm labor; Prostaglandins

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLOOXYGENASE 2; CYTOKINE; ESTROGEN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYOSIN LIGHT CHAIN KINASE; NEUTROPHIL COLLAGENASE; OXYTOCIN RECEPTOR; PRASTERONE SULFATE; PROSTAGLANDIN; RANTES; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; UROKINASE;

BACTERIAL COLONIZATION; CHILDBIRTH; CIGARETTE SMOKING; CYTOKINE RELEASE; GENE; HUMAN; HYDRAMNIOS; IGF1 GENE; IL10 GENE; IL1BETA GENE; IL1RN GENE; IL4 GENE; IL6 GENE; IL8 GENE; INTRAUTERINE INFECTION; MMP1 GENE; MMP8 GENE; MMP9 GENE; MOLECULAR MECHANICS; PATHOPHYSIOLOGY; PERINATAL MORBIDITY; PERINATAL MORTALITY; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; REVIEW; STRESS; TGFBETA1 GENE; TNFALPHA GENE; UTERINE CERVIX INCOMPETENCE; UTERUS CONTRACTION;

ADOLESCENT; ADULT; CYTOKINES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; INFANT, NEWBORN; INFLAMMATION; METALLOPROTEASES; OBSTETRIC LABOR, PREMATURE; POLYHYDRAMNIOS; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY, MULTIPLE; PREMATURE BIRTH; PROSTAGLANDINS; RISK FACTORS; SMOKING; STRESS; UTERINE CERVICAL INCOMPETENCE;

EID: 27144502633     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (160)

1. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med 1998;339:313-20.
2. Villar J, Ezcurra EJ, de la Fuente VG, Canpodonico L. Preterm delivery syndrome: the unmet need. Res Clin Forums 1994;16:9-33.
3. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: final data for 2002. Natl Vital Stat Rep 2003;52:1
4. Robertson PA, Sniderman SH, Laros RK Jr, Cowan R, Heilbron D, Goldenberg RL et al. Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 through 1986. Am J Obstet Gynecol 1992;166:1629-41.
5. Tucker JM, Tucker JM, Goldenberg RL, Davis RO, Copper RL, Winkler CL et al. Etiologies of preterm birth in an indigent population: is prevention a logical expectation? Obstet Gynecol 1991;77:343-7.
6. Norwitz ER, Robinson JN, Challis JRG. The control of labor. N Engl J Med 1999;341:660-6.
7. Romero R, Avila C, Brekus CA, Morotti R. The role of systemic and intrauterine infection in preterm parturition. Ann NY Acad Sci 1991;662:355-75.
8. Challis JRG, Gibb W. Control of parturition. Prenat Neonat Med 1996;1:283.
9. Norwitz ER, Robinson JN, Repke JT. Labor and Delivery. In: Gabbe SG, Niebyl JR, Simpson JL editors. Obstetrics: Normal and Problem Pregnancies. 4th ed. New York: W.B. Saunders Company; 2001. p. 353-94.
10. Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: two distinct sub-groups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993;168:585-91.
11. Berkowitz GS, Kasl SV. The role of psychosocial factors in spontaneous preterm delivery. J Psychosom Res 1983;27:283-90.
12. Lobel M, Dunkel-Schetter C, Scrimshaw SC. Prenatal maternal stress and prematurity: a prospective study of socioeconomically disadvantaged women. Health Psychol 1992;11:32-40.
13. Copper RL, Goldenberg RL, Das A, Elder N, Swain M, Norman G et al. The preterm prediction study: maternal stress is associated with spontaneous preterm birth at less than thirty-five weeks' gestation. Am J Obstet Gynecol 1996;175:1286-92.
14. Ott WJ. Intrauterine growth retardation and preterm delivery. Am J Obstet Gynecol 1993;168:1710-5.
15. Salafia CM, Ghidini A, Lopez-Zeno JA, Pezzullo JC. Uteroplacental pathology and maternal arterial mean blood pressure in spontaneous prematurity. J Soc Gynecol Investig 1998;5:68-71.
16. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nat Med 1995;1:460-3.
17. Korebrits C, Ramirez MM, Watson L, Brinkman E, Bocking AD, Challis JR. Maternal cortico-tropin-releasing hormone is increased with impending preterm birth. J Clin Endocrinol Metab 1998;83:1585-91.
18. Zoumakis E, Makrigiannakis A, Margioris AN, Stournaras C, Gravanis A. Endometrial cortico-tropin-releasing hormone. Its potential autocrine and paracrine actions. Ann N Y Acad Sci 1997;828:84-94.
19. Petraglia F, Potter E, Cameron VA, Sutton S, Behan DP, Woods RJ et al. Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J Clin Endocrinol Metab 1993;77:919-24.
20. Jones SA, Brooks AN, Challis JR. Steroids modulate corticotropin- releasing hormone production in human fetal membranes and placenta. J Clin Endocrinol Metab 1989;68:825-30.
21. Petraglai F, Coukos G, Volpe A, Genazzani AR, Vale W. Involvement of placental neurohormones in human parturition. Ann N Y Acad Sci 1991;622:331-40.
22. Lockwood CJ, Radunovic N, Nastic D, Petkovic S, Aigner S, Berkowitz GS. Corticotropin-releasing hormone and related pituitary-adrenal axis hormones in fetal and maternal blood during the second half of pregnancy. J Perinat Med 1996;24:243-51.
23. Perkins AV, Eben F, Wolfe CD, Schulte HM, Linton EA. Plasma measurements of corticotrophin-releasing hormone-binding protein in normal and abnormal human pregnancy. J Endocrinol 1993;138:149-57.
24. Gibb W. The role of prostaglandins in human parturition. Ann Med 1998;30:235-41.
25. Grammatopoulos DK, Hillhouse EW. Role of corticotropin-releasing hormone in onset of labour. Lancet 1999;354:1546-9.
26. Hobel CJ, Dunkel-Schetter C, Roesch SC, Castro LC, Arora CP. Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery. Am J Obstet Gynecol 1999;180 (1 Pt 3):S257-63.
27. Wadhwa PD, Porto M, Garite TJ, Chicz-DeMet A, Sandman CA. Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy. Am J Obstet Gynecol 1998;179:1079-85.
28. Leung TN, Chung TK, Madsen G, McLean M, Chang AM, Smith R. Elevated mid-trimester maternal corticotrophin-releasing hormone levels in pregnancies that delivered before 34 weeks. Br J Obstet Gynaecol 1999;106:1041-6.
29. Challis JR, Hooper S. Birth: outcome of a positive cascade. Baillieres Clin Endocrinol Metab 1989;3:781-93.
30. Smith R, Mesiano S, Chan EC, Brown S, Jaffe RB. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab 1998;83:2916-20.
31. Chakravorty A, Mesiano S, Jaffe RB. Corticotropin-releasing hormone stimulates P450 17alpha-hydroxylase/17,20-lyase in human fetal adrenal cells via protein kinase C. J Clin Endocrinol Metab 1999;84:3732-8.
32. Lye SJ, Nicholson BJ, Mascarenhas M, MacKenzie L, Petrocelli T. Increased expression of connexin-43 in the rat myometrium during labor is associated with an increase in the plasma estrogen:progesterone ratio. Endocrinology 1993;132:2380-6.
33. Bale TL, Dorsa DM. Cloning, novel promoter sequence, and estrogen regulation of a rat oxytocin receptor gene. Endocrinology 1997;138:1151-8.
34. Windmoller R, Lye SJ, Challis JR. Estradiol modulation of ovine uterine activity. Can J Physiol Pharmacol 1983;61:722-8.
35. Matsui K, Higashi K, Fukunaga K, Miyazaki K, Maeyama M, Miyamoto E. Hormone treatments and pregnancy alter myosin light chain kinase and calmodulin levels in rabbit myometrium. J Endocrinol 1983;97:11-9.
36. Ou CW, Orsino A, Lye SJ. Expression of connexin-43 and connexin-26 in the rat myometrium during pregnancy and labor is differentially regulated by mechanical and hormonal signals. Endocrinology 1997;138:5398-407.
37. Nemeth E, Millar LK, Bryant-Greenwood G. Fetal membrane distention: II. Differentially expressed genes regulated by acute distention in vitro. Am J Obstet Gynecol 2000;182:60-7.
38. Williams MA, Mittendorf R, Lieberman E, Monson RR. Adverse infant outcomes associated with first-trimester vaginal bleeding. Obstet Gynecol 1991;78:14-8.
39. Harger JH, Hsing AW, Tuomala RE, Gibbs RS, Mead PB, Eschenbach DA et al. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol 1990;163:130-7.
40. Ekwo EE, Gosselink CA, Moawad A. Unfavorable outcome in penultimate pregnancy and premature rupture of membranes in successive pregnancy. Obstet Gynecol 1992;80:166-72.
41. Strobino B, Pantel-Silverman J. Gestational vaginal bleeding and pregnancy outcome. Am J Epidemiol 1989;129:806-15.
42. Elovitz MA, Ascher-Landsberg J, Saunders T, Phillippe M. The mechanisms underlying the stimulatory effects of thrombin on myometrial smooth muscle. Am J Obstet Gynecol 2000;183:674-81.
43. Lam H, Hamar B, Rosen T, Schatz F, Lockwood CJ. Thrombin effects on endometrial stromal cell levels of matrix metalloproteinase-1 and metalloproteinase-3 may provide a link between bleeding and rupture of the fetal membranes. Am J Obstet Gynecol 1999;180:S3.
44. Lockwood CJ, Krikun G, Aigner S, Schatz F. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential. J Clin Endocrinol Metab 1996;81:107-12.
45. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988;31:553-84.
46. Gomez R, Romero R, Edwin SS, David C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am 1997;11:135-76.
47. Lockwood CJ, Kuczynski E. Markers of risk for preterm delivery. J Perinat Med 1999;27:5-20.
48. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500-7.
49. Romero R, Gomez R, Chaiworapongsa T, Conoscenti G, Kim JC, Kim YM. The role of infection in preterm labour and delivery. Paediatr Perinat Epidemiol 2001;15: S41-56.
50. Goncalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002;8:3-13.
51. Andrews WW, Hauth JC, Goldenberg RL, Gomez R, Romero R, Cassell GH. Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. Am J Obstet Gynecol 1995;173:606-12.
52. Moretti M, Sibai BM. Maternal and perinatal outcome of expectant management of premature rupture of membranes in the midtrimester. Am J Obstet Gynecol 1988;159:390-6.
53. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988;319:972-8.
54. Asrat T. Intra-amniotic infection in patients with preterm prelabor rupture of membranes. Pathophysiology, detection, and management. Clin Perinatol 2001;28:735-51.
55. Romero R, Emamian M, Wan M, Quintero R, Hobbins JC, Mitchell MD. Prostaglandin concentrations in amniotic fluid of women with intra-amniotic infection and preterm labor. Am J Obstet Gynecol 1987;157:1461-7.
56. Edwin S, Trautman MS, Mitchell MD. Regulation of prostaglandin H synthase-2 in chorion and decidual cells. Prostaglandins Leukot Essent Fatty Acids 1996;55:211-6.
57. Romero R, Durum S, Dinarello CA, Oyarzun E, Hobbins JC, Mitchell MD. Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglandins 1989;37:13-22.
58. Van Mier CA, Sangha RK, Walton JC, Matthews SG, Keirse MJ, Challis JR. Immunoreactive 15-hydroxyprostaglandin dehydrogenase (PGDH) is reduced in fetal membranes from patients at preterm delivery in the presence of infection. Placenta 1996;17:291-7.
59. Lei H, Furth EE, Kalluri R, Chiou T, Tilly KI, Tilly JL et al. A program of cell death and extracellular matrix degradation is activated in the amnion before the onset of labor. J Clin Invest 1996;98:1971-8.
60. Romero R, Mazor M, Munoz H, Gomez R, Galasso M, Sherer DM. The preterm labor syndrome. Ann N Y Acad Sci 1994;734:4l4-29.
61. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F et al. Amniotic fluid cytokines (interleukin-6, tumor - necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825-30.
62. Kazzi SN, Kim UO, Quasney MW, Buhimschi I. Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics 2004;114:243-8.
63. Dammann O, Leviton A, Gappa M, Dammann CE. Lung and brain damage in preterm newborns, and their association with gestational age, prematurity subgroup, infection/inflammation and long term outcome. Br J Obstet Gynaecol 2005;112:S4-9.
64. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;179:186-93.
65. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194-202.
66. Cohen S, Bigazzi PE, Yoshida T. Similarities of T cell function in cell-mediated immunity and antibody production. Cell Immunol 1974;12:150-9.
67. Vilcek J, Le J. Immunology of cytokines. In: Thompson A editor. The Cytokine Handbook. London: Academic Press; 1991. p. 1-18.
68. Saito S, Kasahara T, Kato Y, Ishihara Y, Ichijo M. Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 1993;5:81-8.
69. Steinborn A, Gatje R, Kramer P, Kuhnert M, Halberstadt E. [Cytokines in the diagnosis of amniotic infection syndrome] Z Geburtshilfe Perinatol 1994;198:1-5. German.
70. Lockwood CJ, Ghidini A, Wein R, Lapinski R, Casal D, Berkowitz RL. Increased interleukin-o concentrations in cervical secretions are associated with preterm delivery. Am J Obstet Gynecol 1994;171:1097-102.
71. Goldenberg RL, Andrews WW, Mercer BM, Moawad AH, Meis PJ, lams JD et al. The preterm prediction study: granulocyte colony-stimulating factor and spontaneous preterm birth. Am J Obstet Gynecol 2000;182:625-30.
72. Yoon BH, Oh SY, Romero R, Shim SS, Han SY, Park JS et al. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2001;185:1162-7.
73. Casey ML, MacDonald PC. Biomolecular processes in the initiation of parturition: decidual activation. Clin Obstet Gynecol 1988;31:533-52.
74. Trautman MS, Edwin SS, Collmer D, Dudley DJ, Simmons D, Mitchell MD. Prostaglandin H synthase-2 in human gestational tissues: regulation in amnion. Placenta 1996;17:239-45.
75. Bry K, Hallman M, Lappalainen U. Cytokines released by granulocytes and mononuclear cells stimulate amnion cell prostaglandin E2 production. Prostaglandins 1994;48:389-99.
76. Dinarello CA. Interleukin-1. In: Thompson A editor. The Cytokine Handbook. London: Academic Press; 1991. p. 47-82.
77. Romero R, Wu YK, Brody DT, Oyarzun E, Duff GW, Durum SK. Human decidua: a source of interleukin-1. Obstet Gynecol 1989;73:31-4.
78. Taniguchi T, Matsuzaki N, Kameda T, Sasano H. The enhanced production of placental interleukin-1 during labor and intrauterine infection. Am J Obstet Gynecol 1991;165:131-7.
79. Romero R, Durum S, Dinarello CA, Oyarzun E, Hobbins JC, Mitchell MD. Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglandins 1989;37:13-22.
80. Romero R, Brody DT, Oyarzun E, Mazor M, Wu YK, Hobbins JC et al. Infection and labor. III. Interleukin-1: a signal for the onset of parturition. Am J Obstet Gynecol 1989;160:1117-23.
81. Romero R, Mazor M, Brandt F, Sepulveda W, Avila C, Cotton DB et al. Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. Am J Reprod Immunol 1992;27:117-23.
82. Romero R, Mazor M, Tartakovsky B. Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol 1991;165:969-71.
83. Hirsch E, Muhle RA, Mussalli GM, Blanchard R. Bacterially induced preterm labor in the mouse does not require maternal interleukin-1 signaling. Am J Obstet Gynecol 2002;186:523-30.
84. Romero R, Mazor M, Manogue K, Oyarzun E, Cerami A. Human decidua: a source of cachectin-tumor necrosis factor. Eur J Obstet Gynecol Reprod Biol 1991;41:123-7.
85. Romero R, Manogue KR, Mitchell MD, Wu YK, Oyarzun E, Hobbins JC et al. Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 1989;161:336-41.
86. Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 1992;166:1576-87.
87. Silver RM, Lohner WS, Daynes RA, Mitchell MD, Branch DW. Lipopolysaccharide-induced fetal death: The role of tumor-necrosis factor alpha. Biol Reprod 1994;50:1108-12.
88. Matsuzaki N, Saji F, Kameda T, Yoshizaki K, Okada T, Sawai K et al. In vitro and in vivo production of interleukin-6 by fetal mononuclear cells. Clin Immunol Immunopathol 1990;55:305-14.
89. Mitchell MD, Dudley DJ, Edwin SS, Schiller SL. Interleukin-6 stimulates prostaglandin production by human amnion and decidual cells. Eur J Pharmacol 1991;192:189-91.
90. Rizzo G, Capponi A, Rinaldo D, Tedeschi D, Arduini D, Romanini C. Interleukin-6 concentrations in cervical secretions identify microbial invasion of the amniotic cavity in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1996;175:812-7.
91. Romero R, Yoon BH, Mazor M, Gomez R, Diamond MP, Kenney JS et al. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1993;169:805-16.
92. Romero R, Yoon BH, Mazor M, Gomez R, Gonzalez R, Diamond MP et al. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1993;169:839-51.
93. Wenstrom KD, Andrews WW, Hauth JC, Goldenberg RL, DuBard MB, Cliver SP. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol 1998;178:546-50.
94. Yoon BH, Romero R, Yang SH, Jun JK, Kim IO, Choi JH et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996;174:1433-40.
95. Ghezzi F, Gomez R, Romero R, Yoon BH, Edwin SS, David C et al. Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol 1998;78:5-10.
96. Chaiworapongsa T, Romero R, Tolosa JE, Yoshimatsu J, Espinoza J, Kim YM et al. Elevated monocyte chemotactic protein-1 in amniotic fluid is a risk factor for pregnancy loss. J Matern Fetal Neonatal Med 2002;12:159-64.
97. Simonet WS, Hughes TM, Nguyen HQ, Trebasky LD, Danilenko DM, Medlock ES. Long-term impaired neutrophil migration in mice over-expressing human interleukin-8. J Clin Invest 1994;94:1310-9.
98. Abbas AK, Lichtman AH, Pober JS. Cellular and Molecular Immunolgy. Philadelphia: W.B.Saunders Company, 2000.
99. Romero R, Ceska M, Avila C, Mazor M, Behnke E, Lindley I. Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol 1991;165:813-20.
100. Hsu CD, Meaddough E, Aversa K, Copel JA. The role of amniotic fluid L-selectin, GRO-alpha, and interleukin-8 in the pathogenesis of intraamniotic infection. Am J Obstet Gynecol 1998;178:428-32.
101. Cherouny PH, Pankuch GA, Romero R, Botti JJ, Kuhn DC, Demers LM et al, Neutrophil attractant/activating peptide-1/interleukin-8: association with histologic chorioamnionitis, preterm delivery, and bioactive amniotic fluid leukoattractants. Am J Obstet Gynecol 1993;169:1299-303.
102. Christman JW, Blackwell TR, Cowan HB, Shepherd VL, Rinaldo JE. Endotoxin induces the expression of macrophage inflammatory protein 1 alpha mRNA by rat alveolar and bone marrow-derived macrophages. Am J Respir Cell Mol Biol 1992;7:455-61.
103. Romero R, Gomez R, Galasso M, Varner MW. Macrophage inflammatory protein-1 alpha in term and preterm parturition: effect of microbial invasion of the amniotic cavity. Am J Reprod Immunol 1994;32:108-13.
104. Dudley DJ, Hunter C, Mitchell MD, Varner MW. Elevations of amniotic fluid macrophage inflammatory protein-1 alpha concentrations in women during term and preterm labor. Obstet Gynecol 1996;87:94-8.
105. Geiser T, Dewald B, Ehrengruber MU, Clark-Lewis I, Baggiolini M. The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes. J Biol Chem 1993;268:15419-24.
106. Cohen J, Ghezzi F, Romero R, Ghidini A, Mazor M, Tolosa JE et al. GRO alpha in the fetomaternal and amniotic fluid compartments during pregnancy and parturition. Am J Reprod Immunol 1996;35:23-9.
107. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001;12:53-72.
108. Dinarello CA. Interleukin-18. Methods 1999;19:121-32.
109. Biet F, Locht C, Kremer L. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med 2002;80:147-62.
110. Menon R, Lombardi SJ, Fortunate SJ. IL-18, a product of choriodecidual cells, increases during premature rupture of membranes but fails to turn on the Fas-FasL-mediated apoptosis pathway. J Assist Reprod Genet 2001;18:276-84.
111. Pacora P, Romero R, Maymon E, Gervasi MT, Gomez R, Edwin SS et al. Participation of the novel cytokine interleukin 18 in the host response to intra-amniotic infection. Am J Obstet Gynecol 2000;183:1138-43.
112. Jacobsson B, Hoist RM, Mattsby-Baltzer I, Nikolaitchouk N, Wennerholm UB, Hagberg H. Interleukin-18 in cervical mucus and amniotic fluid: relationship to microbial invasion of the amniotic fluid, intra-amniotic inflammation and preterm delivery. Br J Obstet Gynaecol 2003;110:598-603.
113. Minagawa K, Tsuji Y, Ueda H, Koyama K, Tanizawa K, Okamura H et al. Possible correlation between high levels of IL-18 in the cord blood of pre-term infants and neonatal development of periventricular leukomalacia and cerebral palsy. Cytokine 2002;17:164-70.
114. Denison FC, Kelly RW, Calder AA, Riley SC. Cytokine secretion by human fetal membranes, decidua and placenta at term. Hum Reprod 1998;13:3560-5.
115. Sugano T, Narahara H, Nasu K, Arima K, Fujisawa K, Miyakawa I. Effects of platelet-activating factor on cytokine production by human uterine cervical fibroblasts. Mol Hum Reprod 2001;7:475-81.
116. Denison FC, Riley SC, Elliott CL, Kelly RW, Calder AA, Critchley HO. The effect of mifepristone administration on leukocyte populations, matrix metalloproteinases and inflammatory mediators in the first trimester cervix. MoI Hum Reprod 2000;6:541-8.
117. Sennstrom MB, Ekman G, Westergren-Thorsson G, Norstrom A. Human cervical ripening, an inflammatory process mediated by cytokines. Mol Hum Reprod 2000;6:375-81.
118. Bokstrom H, Brannstrom M, Alexandersson M, Norstrom A. Leukocyte subpopulations in the human uterine cervical stroma at early and term pregnancy. Hum Reprod 1997;12:586-90.
119. Ludmir J, Sehdev HM. Anatomy and physiology of the uterine cervix. Clin Obstet Gynecol 2000;43:433-9.
120. Junqueira LC, Zugaib M, Montes GS, Toledo OM, Krisztan RM, Shigihara KM. Morphologic and histochemical evidence for the occurrence of collagenolysis and for the role of neutrophilic polymorphonuclear leukocytes during cervical dilation. Am J Obstet Gynecol 1980;138:273-81.
121. Kayisli UA, Mahutte NG, Arici A. Uterine chemokines in reproductive physiology and pathology. Am J Reprod Immunol 2002;47:213-21.
122. Athayde N, Romero R, Maymon E, Gomez R, Pacora P, Araneda H et al. A role for the novel cytokine RANTES in pregnancy and parturition. Am J Obstet Gynecol 1999;181:989-94.
123. Kent AS, Sullivan MH, Elder MG. Transfer of cytokines through human fetal membranes. J Reprod Fertil 1994;100:81-4.
124. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998;44:665-75.
125. Baier RJ, Loggins J, Kruger TE. Increased interleukin-8 and monocyte chemoattractant protein-1 concentrations in mechanically ventilated preterm infants with pulmonary hemorrhage. Pediatr Pulmonol 2002;34:131-7.
126. Maymon E, Romero R, Pacora P, Gomez R, Athayde N, Edwin S et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol 2000;183:94-9.
127. Park JS, Romero R, Yoon BH, Moon JB, Oh SY, Han SY et al. The relationship between amniotic fluid matrix metalloproteinase-8 and funisitis. Am J Obstet Gynecol 2001;185:1156-61.
128. Moore KW, Ho ASY, Xu-Amano J. Molecular biology of interleukin-10 and its receptor. In: Vries JE, Waal Malefyt R, editors. Interleukin-10. Austin: REG Landes Co; 1995. p. 1-10.
129. Boulay JL, Paul WE. The interleukin-4-related lymphokines and their binding to hematopoietin receptors. J Biol Chem 1992;267:20525-8.
130. Sporn MB, Roberts AB. Transforming growth factor-beta: recent progress and new challenges. J Cell Biol 1992;119:1017-21.
131. Hata T, Kawamura T, Fujiwaki R, Aoki S, Hata K, Inada K. Interleukin-4, interleukin-10, and soluble tumor necrosis factor receptors in cord blood. Gynecol Obstet Invest 1997;43:155-7.
132. Greig PC, Herbert WN, Robinette BL, Teot LA. Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection. Am J Obstet Gynecol 1995;173:1223-7.
133. Dudley DJ, Hunter C, Mitchell MD, Varner MW. Amniotic fluid interleukin-10 (IL-10) concentrations during pregnancy and with labor. J Reprod Immunol 1997;33:147-56.
134. Matsubara S, Yamada T, Minakami H, Watanabe T, Takizawa T, Sato I. Polymorphonuclear leukocytes in the fetal membranes are activated in patients with preterm delivery: ultrastructural and enzyme-histochemical evidence. Placenta 1999;20:185-8.
135. Halgunset J, Johnsen H, Kjollesdal AM, Qvigstad E, Espevik T, Austgulen R. Cytokine levels in amniotic fluid and inflammatory changes in the placenta from normal deliveries at term. Eur J Obstet Gynecol Reprod Biol 1994;56:153-60.
136. Negishi H, Yamada H, Mikuni M, Kishida T, Okuyama K, Sagawa T et al. Correlation between cytokine levels of amniotic fluid and histological chorioamnionitis in preterm delivery. J Perinat Med 1996;24:633-9.
137. Hunt JS. Cytokine networks in the uteroplacental unit: macrophages as pivotal regulatory cells. J Reprod Immunol 1989;16:1-17.
138. Menon R, Swan KF, Lyden TW, Rote NS, Fortunate SJ. Expression of inflammatory cytokines (interleukin-1 beta and interleukin-6) in amniochorionic membranes. Am J Obstet Gynecol 1995;172:493-500.
139. Fortunate SJ, Menon R, Swan KF. Amniochorion: a source of interleukin-8. Am J Reprod Immunol 1995;34:156-62.
140. Reisenberger K, Egarter C, Vogl S, Sternberger B, Kiss H, Husslein P. The transfer of interleukin-8 across the human placenta perfused in vitro. Obstet Gynecol 1996;87:613-6.
141. Iams JD, Goldenberg RL, Mercer BM, Moawad A, Thom E, Meis PJ et al. The Preterm Prediction Study: recurrence risk of spontaneous preterm birth. Am J Obstet Gynecol 1998;178:1035-40.
142. Winkvist A, Mogren I, Hogberg U. Familial patterns in birth characteristics: impact on individual and population risks. Int J Epidemiol 1998;27:248-54.
143. Carmichael SL, Iyasu S, Hatfield-Timajchy K. Cause-specific trends in neonatal mortality among black and white infants, United States, 1980-1995. Matern Child Health J 1998;2:67-76.
144. Ventura SJ, Bachrach CA. Nonmarital childbearing in the United States, 1940-99. Natl Vital Stat Rep 2000;48:1-40.
145. Blackmore CA, Ferre CD, Rowley DL, Hogue CJ, Gaiter J, Atrash H. Is race a risk factor or a risk marker for preterm delivery? Ethn Dis 1993;3:372-7.
146. Blackmore-Prince C, Kieke B Jr, Kugaraj KA, Ferre C, Elam-Evans LD, Krulewitch CJ et al. Racial differences in the patterns of singleton preterm delivery in the 1988 National Maternal and Infant Health Survey. Matern Child Health J 1999;3:189-97.
147. Ekwo E, Moawad A. The risk for recurrence of premature births to African-American and white women. J Assoc Acad Minor Phys 1998;9:16-21.
148. Mercer BM, Goldenberg RL, Moawad AH, Meis PJ, lams JD, Das AF et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. Am J Obstet Gynecol 1999;181:1216-21.
149. Liggins GC. Initiation of labor. Biol Neonate 1989;55:366-94.
150. Klebanoff MA, Carey JC, Heath JC, Hillier SL, Nugent RP, Thom EA et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-93.
151. Jeffcoat MK, Geurs NC, Reddy MS, Goldenberg RL, Hauth JC. Current evidence regarding periodontal disease as a risk factor in preterm birth. Ann Periodontol 2001;6:183-8.
152. Goepfert AR, Jeffcoat MK, Andrews WW, Faye-Petersen O, Cliver SP, Goldenberg RL et al. Periodontal disease and upper genital tract inflammation in early spontaneous preterm birth. Obstet Gynecol 2004;104:777-83.
153. Genç MR, Onderdonk AB, Vardhana S, Delaney ML, Norwitz ER, Tuomala RE et al, Polymorphism in intron 2 of the interleukin-1 receptor antagonist gene, local midtrimester cytokine response to vaginal flora, and subsequent preterm birth. Am J Obstet Gynecol 2004;191:1324-30.
154. Genç MR, Vardhana S, Delaney ML, Onderdonk A, Tuomala R, Norwitz E et al. Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol 2004;116:152-6.
155. Nguyen DP, Genç MR, Vardhana S, Babula O, Onderdonk A, Witkin SS. Ethnic differences of polymorphisms in cytokine and innate immune system genes in pregnant women. Obstet Gynecol 2004;104:293-300.
156. Macones GA, Parry S, Elkousy M, Clothier B, Ural SH, Strauss JF 3rd. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol 2004;190:1504-8.
157. Genç MR, Vardhana S, Delaney ML, Witkin SS, Onderdonk A. TNF -308 G>A polymorphism influences the TNF response to altered vaginal flora and pregnancy outcome. Am J Obstet Gynecol 2005;191:8105.
158. Annells MF, Hart PH, Mullighan CG, Heatley SL, Robinson JS, Bardy P et al. Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: risk of preterm birth. Am J Obstet Gynecol 2004;191:2056-67.
159. Genç MR, Witkin SS, Delaney ML, Paraskevas LR, Tuomala RE, Norwitz ER et al. A disproportionate increase in IL-1(over IL-Ira in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth. Am J Obstet Gynecol 2004;190:1191-7.
160. Nguyen DP, Genç M, Vardhana S, Babula O, Onderdonk A, Witkin SS. Ethnic differences of polymorphisms in cytokine and innate immune system genes in pregnant women. Obstet Gynecol 2004;104:293-300.